Solid Biosciences Inc.
SLDBNASDAQHealthcare● Active
$6.41
$-0.29(-4.33%)
Market Cap$499404382
P/E Ratio—
52W High$8.866
52W Low$3.675
Solid Biosciences Inc. (SLDB) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SLDB · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.52
Est. -$0.40 · -30.0%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▼ Miss EPS
SLDB reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | -$0.43 | — | — | — | — | — |
| ▼ Q2 FY2026 | May 12, 2026 | -$0.40 | -$0.52 | -30.0% | — | — | — |
| ▲ Q1 FY2026 | Mar 19, 2026 | -$0.51 | -$0.50 | +2.0% | — | — | — |
| ▼ Q4 FY2025 | Nov 3, 2025 | -$0.42 | -$0.48 | -14.3% | — | — | — |
| ▲ Q3 FY2025 | Aug 12, 2025 | -$0.51 | -$0.42 | +17.6% | — | — | — |
| ▼ Q2 FY2025 | May 15, 2025 | -$0.53 | -$0.59 | -11.3% | — | — | — |
| ▼ Q1 FY2025 | Mar 6, 2025 | -$0.79 | -$0.89 | -12.7% | — | — | — |
| ▼ Q4 FY2024 | Nov 6, 2024 | -$0.67 | -$0.79 | -17.9% | — | — | — |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
-$0.43
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Miss
EPS Actual
-$0.52
EPS Est.
-$0.40
EPS Surpr.
-30.0%
Revenue
—
Q1 FY2026
Mar 19, 2026Beat
EPS Actual
-$0.50
EPS Est.
-$0.51
EPS Surpr.
+2.0%
Revenue
—
Q4 FY2025
Nov 3, 2025Miss
EPS Actual
-$0.48
EPS Est.
-$0.42
EPS Surpr.
-14.3%
Revenue
—
Q3 FY2025
Aug 12, 2025Beat
EPS Actual
-$0.42
EPS Est.
-$0.51
EPS Surpr.
+17.6%
Revenue
—
Q2 FY2025
May 15, 2025Miss
EPS Actual
-$0.59
EPS Est.
-$0.53
EPS Surpr.
-11.3%
Revenue
—
Q1 FY2025
Mar 6, 2025Miss
EPS Actual
-$0.89
EPS Est.
-$0.79
EPS Surpr.
-12.7%
Revenue
—
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
-$0.79
EPS Est.
-$0.67
EPS Surpr.
-17.9%
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.59 | $-0.59 | $-0.59 | 4 |
| Q3 FY2028 | $-0.60 | $-0.60 | $-0.60 | 6 |
| Q2 FY2028 | $-0.55 | $-0.55 | $-0.55 | 4 |
| Q1 FY2028 | $-0.57 | $-0.57 | $-0.57 | 4 |
| Q4 FY2027 | $-0.49 | $-0.49 | $-0.49 | 3 |
| Q3 FY2027 | $-0.51 | $-0.51 | $-0.51 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 12, 2026 | -30.0% | $7.68 | $7.72 | +0.52% |
| ▲ Q1 FY2026 | Mar 19, 2026 | +2.0% | $7.12 | $7.12 | +0.00% |
| ▼ Q4 FY2025 | Nov 3, 2025 | -14.3% | $5.39 | $5.20 | -3.53% |
| ▲ Q3 FY2025 | Aug 12, 2025 | +17.6% | $6.08 | $6.04 | -0.66% |
| ▼ Q2 FY2025 | May 15, 2025 | -11.3% | $2.55 | $2.59 | +1.57% |
| ▼ Q1 FY2025 | Mar 6, 2025 | -12.7% | $5.76 | $5.50 | -4.51% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -17.9% | $5.94 | $6.14 | +3.37% |
| ▲ Q3 FY2024 | Aug 13, 2024 | +10.3% | $7.16 | $7.29 | +1.82% |
Q2 FY2026+0.52%
Report Date
May 12, 2026
EPS Beat/Miss
-30.0%
Price Before
$7.68
Price After
$7.72
Q1 FY2026+0.00%
Report Date
Mar 19, 2026
EPS Beat/Miss
+2.0%
Price Before
$7.12
Price After
$7.12
Q4 FY2025-3.53%
Report Date
Nov 3, 2025
EPS Beat/Miss
-14.3%
Price Before
$5.39
Price After
$5.20
Q3 FY2025-0.66%
Report Date
Aug 12, 2025
EPS Beat/Miss
+17.6%
Price Before
$6.08
Price After
$6.04
Q2 FY2025+1.57%
Report Date
May 15, 2025
EPS Beat/Miss
-11.3%
Price Before
$2.55
Price After
$2.59
Q1 FY2025-4.51%
Report Date
Mar 6, 2025
EPS Beat/Miss
-12.7%
Price Before
$5.76
Price After
$5.50
Q4 FY2024+3.37%
Report Date
Nov 6, 2024
EPS Beat/Miss
-17.9%
Price Before
$5.94
Price After
$6.14
Q3 FY2024+1.82%
Report Date
Aug 13, 2024
EPS Beat/Miss
+10.3%
Price Before
$7.16
Price After
$7.29
Avg Beat Reaction+0.39%
Avg Miss Reaction-0.52%
Beat Rate3 / 8 quarters
Largest Move-4.51% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SLDB ends December
Solid Biosciences Inc. (SLDB) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.52 — missing the analyst consensus of $-0.40 by -30.0%. The next SLDB earnings date is expected around September 1, 2026.
Each quarter, investors track SLDB earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SLDB revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SLDB's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SLDB earnings · 5 questionsSolid Biosciences Inc.'s next earnings report is expected around September 1, 2026. SLDB typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SLDB historically reports after market close (AMC).
SLDB earnings datewhen is SLDB earningsSLDB next earnings datewhen does SLDB report earningsSLDB earnings calendar
▸ Source: FMP · Solid Biosciences Inc. SEC filings · US GAAP · Solid Biosciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026